![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-84100cea1d7865b4041050fe68760adb4393cc025da77fe5f9f30119abf299a1.jpg)
Infliximab for Immune Checkpoint Inhibitor Therapy-Related Toxicities
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.